Infectious Diseases
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
March 20, 2017
March 13, 2017
March 6, 2017
March 1, 2017
February 27, 2017
February 21, 2017
February 20, 2017
February 13, 2017
February 8, 2017
February 6, 2017
January 30, 2017
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community